Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1585 results about "Mechanism of action" patented technology

In pharmacology, the term mechanism of action (MOA) refers to the specific biochemical interaction through which a drug substance produces its pharmacological effect. A mechanism of action usually includes mention of the specific molecular targets to which the drug binds, such as an enzyme or receptor. Receptor sites have specific affinities for drugs based on the chemical structure of the drug, as well as the specific action that occurs there. Drugs that do not bind to receptors produce their corresponding therapeutic effect by simply interacting with chemical or physical properties in the body. Common examples of drugs that work in this way are antacids and laxatives.

Drug screening and disease model construction method for liver organoid

The invention provides a method for drug screening and disease model construction of liver organoid, relates to the technical field of medical research, and adopts multi-modal data acquisition, fusion and intelligent analysis and quantum computing processing to optimize comprehensive application of data, so that the richness, accuracy and analysis efficiency of the data are remarkably improved, and the risk of drug screening and disease model construction of liver organoid is reduced. Multi-source data of genomics, transcriptomics and the like are collected comprehensively, an accurate research system of immune-hepatic disease interaction based on organoid is constructed, an in-vivo complex immune-hepatic disease microenvironment can be highly simulated, the proportion and activation state of immune cells are accurately regulated and controlled in an in-vitro model, functional and phenotypic changes of the immune cells are monitored in real time, and the immune-hepatic disease interaction accuracy is improved. According to the present invention, the interaction mechanism between the immune cells and the liver organ cells is deeply revealed, such that the accurate information basis is provided for the accurate determination of the drug action target, the development of the innovative drug for the immune check point or tumor microenvironment regulation is easily achieved, and the pertinence and the success rate of the drug research and development are substantially improved.
Owner:TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH

Hippocampus-derived neuroprotective and anti-oxidative stress polypeptide and preparation method thereof

The invention relates to the technical field of hippocampus extract, in particular to a hippocampus-sourced neuroprotection and anti-oxidative stress polypeptide and a preparation method thereof.The amino acid sequence of the polypeptide is shown as SEQ ID No.1. The preparation method comprises the following steps that 1, 500 g of fresh hippocampus is weighed, surface silt is removed, freeze-drying is conducted at the temperature of-60 DEG C, then the hippocampus is smashed through a smashing machine and sieved through a 20-mesh sieve, and the hippocampus extract is obtained; dialyzing with distilled water for 24 hours, and freeze-drying to obtain hippocampus powder; (2) weighing 200g of hippocampus powder, adding 1000ml of 95% ethanol, extracting for three times, removing fat-soluble substances, and extracting and freeze-drying precipitates by using a 1 mol / L NaCl solution under the condition of 4 DEG C in combination with ultrasonic assistance to obtain crude hippocampus protein; (3) the hippocampus crude protein is taken, the hippocampus polypeptide is prepared through an ultrasonic-assisted bionic digestion method, and the hippocampus polypeptide has the advantages of being specific in molecular structure, clear in action mechanism, stable in gastrointestinal tracts, capable of protecting nerves, resistant to oxidative stress and the like.
Owner:WEIHAI MARINE BIOMEDICAL IND TECH RES INST CO LTD

Lactobacillus reuteri HNU872 and application thereof in preparation of intestinal inflammation related products

The invention provides lactobacillus reuteri HNU872 and application of the lactobacillus reuteri HNU872 in preparation of intestinal inflammation related products. The invention discloses how the Lactobacillus reuteri HNU872 effectively alleviates the phenotype of DSS-induced mouse enteritis. The invention also discloses a preparation method of the Lactobacillus reuteri HNU872. Research results show that the Lactobacillus reuteri HNU872 can significantly relieve weight loss caused by enteritis, improve colon length, significantly improve the level of anti-inflammatory cytokines in serum and reduce the concentration of pro-inflammatory cytokines. In addition, the expression of the intestinal tight junction protein ZO-1 is obviously promoted. The lactobacillus reuteri HNU872 can regulate diversity and structure of intestinal microbiota of mice, inhibit enrichment of pathogenic bacteria and relieve inflammatory response. According to the invention, the action mechanism of the lactobacillus reuteri HNU872 in improving enteritis is clarified, and a solid scientific basis is provided for developing a microbial product based on probiotics as an alternative treatment strategy for ulcerative colitis.
Owner:HAINAN UNIV

Patient immune response monitoring method and system for cell drug clinical research

The invention discloses a patient immune response monitoring method and system for cell drug clinical research, and the method comprises the following steps: 1, obtaining a peripheral blood sample of a patient, and preprocessing the peripheral blood sample to obtain patient sample components; multi-dimensional immune indexes and cell drug specific immune response are detected by comprehensively utilizing multiple technologies, immune cell subsets, cell factors, immune globulin, T cell response and the like are covered, and therefore a complex immune response system is comprehensively reflected; peripheral blood samples are collected at multiple time points according to a cell drug action mechanism and a half-life period, and the whole-course change of the immunoreaction is effectively tracked, so that the development trend of the immunoreaction is accurately grasped; the method has the advantages that the characteristics are visually presented by constructing the immune response atlas of the patient, evaluation and prediction are assisted, real-time monitoring reports and treatment suggestions are provided according to evaluation and prediction results, doctors are assisted to adjust treatment in time, and accordingly the safety and effectiveness of cell drug treatment are improved.
Owner:BEIJING SINOCRO PHARMASCIENCE CO LTD

Intelligent analysis and prediction platform for curative effect of traditional Chinese medicine

The invention discloses a traditional Chinese medicine curative effect intelligent analysis and prediction platform, and relates to the technical field of traditional Chinese medicine analysis. The intelligent management platform is in communication connection with a data preprocessing and standardization module, a symptom description standardization processing module, a network relation analysis module, a network target positioning module, a network target navigation module, a drug effect prediction and evaluation module and a report generation and output module. According to the traditional Chinese medicine curative effect intelligent analysis and prediction platform, by integrating a machine learning technology, the accuracy of traditional Chinese medicine curative effect evaluation is remarkably improved, a large number of traditional Chinese medicine prescriptions, patient syndromes and curative effect data information are collected and analyzed, and the treatment effects of the traditional Chinese medicine prescriptions on different syndromes are evaluated by combining a network target and an established network relationship; and analysis results of the drug target intervention effect and the synergistic effect are provided, so that the action mechanism of the traditional Chinese medicine prescription can be deeply understood, and the traditional Chinese medicine prescription with a potential curative effect can be quickly screened out.
Owner:CHANGCHUN UNIV OF CHINESE MEDICINE

Angiotensin I converting enzyme inhibitory peptide and application thereof

The invention belongs to the technical field of biological medicines, and discloses an angiotensin I converting enzyme inhibitory peptide. According to the present invention, the action mechanisms of two ACE inhibitory peptides H5 (LIIPQH, 719.85 Da) and H6 (LIIPEH, 720.85 Da) extracted, separated and purified from rice wine residue are researched, and the in vitro activity of the ACE inhibitory peptides is researched through an EA.hy926 cell model, such that the two ACE inhibitory peptides can provide the activity effect by promoting the release of NO, the expression of eNOS and SOD, and inhibiting the release secretion of ET-1 and the release of ROS; meanwhile, the cells are subjected to transcriptomics analysis, and the pathway mechanism of polypeptide action is defined. The ACE inhibitory peptide is expected to serve as a potential antihypertensive drug or a functional food ingredient, the high-value utilization of the rice wine residues is improved, and a new application way is provided for the food-borne ACE inhibitory peptide in the aspect of treating hypertension.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Macrophage membrane functionalized manganese dioxide nano-drug as well as preparation method and application thereof in treatment of atherosclerosis

PendingCN119548473AEnhanced Synergistic Healing EffectsExtend cycle timeOrganic active ingredientsInorganic active ingredientsSide effectCholesterol excretion
The invention relates to the technical field of atherosclerosis related drugs, in particular to a macrophage membrane functionalized manganese dioxide nano-drug as well as a preparation method and application thereof in treatment of atherosclerosis. The invention relates to a macrophage membrane functionalized manganese dioxide nano-drug, which comprises an HMnO2 carrier, colchicine is loaded on the HMnO2 carrier, and a macrophage membrane is coated outside the HMnO2 carrier. The preparation can be applied to practical operation of preparing medicines for treating atherosclerosis. According to the technical scheme, the technical problem of limited treatment effect caused by single action mechanism of medicines for treating atherosclerosis in the prior art can be solved. The nano-drug in the scheme can remove ROS to play an anti-inflammatory effect, reprogram macrophages and promote cholesterol excretion, and is used for synergistically treating atherosclerosis. The macrophage membrane can target an inflammation part and escape from an immune system. And the side effect of the nano-drug is relatively small, so that the nano-drug has ideal popularization and application prospects.
Owner:THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIV

Method for constructing Ddx58-R109C point mutation mouse model and application of Ddx58-R109C point mutation mouse model

The invention discloses a method for constructing a Ddx58-R109C point mutation mouse model by using a CRISPR / Cas9 gene editing technology and an application of the Ddx58-R109C point mutation mouse model. The method comprises the following steps: (1) target construction: searching a CDS region of a Ddx58 gene, determining an exon part, and determining a gene mutation site; (2) obtaining a fertilized egg, and injecting Cas9mRNA, gRNA and donor oligo into the fertilized egg of the C57BL / 6J mouse together in vitro through a microinjection technology to obtain an F0-generation hybrid mouse; (3) mating the F0-generation hybrid mouse with the wild type mouse to obtain an F1-generation mouse; (4) the F1-generation heterozygous mice which are identified to be positive are subjected to mating, and homozygous Ddx58-R109C mutant type and wild type mice can be obtained by breeding obtained offspring; (5) phenotypic analysis shows that Ddx58-R109C point mutation mice can have pathological changes of systemic lupus erythematosus and lupus nephritis; the invention can provide an effective research approach and method for researchers to deeply explore the action mechanism of Ddx58-R109C mutation in diseases, and has important significance for explaining the pathogenesis of systemic lupus erythematosus and researching and developing targeted therapeutic drugs.
Owner:NANJING GENERAL HOSPITAL NANJING MILLITARY COMMAND P L A

Construction method of endocrine disruption effect harmful outcome path network

The invention discloses an endocrine disruption effect harmful outcome path network construction method, and relates to the field of endocrine disrupter screening, and the method comprises the steps: obtaining endocrine data; preprocessing the acquired endocrine data; according to the preprocessed endocrine data, constructing an event causal relationship triad reflecting the endocrine disruption effect, wherein the event causal relationship triad comprises a trigger word, a source event and a target event; the data KER1 is used as data KER1; according to the preprocessed endocrine data, acquiring endocrine data of which the confidence coefficient is greater than a preset threshold value from a preset literature database, and taking the acquired endocrine data as data KER2; performing duplicate removal processing on the data KER1 and the data KER2 to obtain final endocrine disruption effect harmful outcome path data; and establishing an endocrine disruption effect harmful outcome path network according to the final endocrine disruption effect harmful outcome path data. In view of insufficient analysis of an action mechanism between an endocrine disrupter and a corresponding bad health outcome in the prior art, the application improves interpretability.
Owner:NANJING UNIV

Circular RNA drug sensitivity correlation identification method based on integrated multi-instance learning

The invention discloses a circular RNA drug sensitivity correlation identification method based on integrated multi-instance learning. The circular RNA drug sensitivity correlation identification method comprises the following steps: collecting experimental verification circular RNA and drug sensitivity correlation data; establishing a feature representation model based on a heterogeneous network and vertexes; embedding a heterogeneous graph node into the model, and extracting deep feature representation of the node; designing a meta-path instance embedding projector, and generating a plurality of meta-path instances; a circular RNA and drug sensitivity association predictor is constructed and completed; constructing an integrated heterogeneous graph network deep learning model; and outputting the meta-path instance of the circular RNA and drug pair and the attention coefficient, and carrying out interpretable analysis. According to the method, integrated learning and a deep learning model are combined, so that the reliability of the model is improved; according to the invention, interpretable analysis is carried out by utilizing the meta-path and the attention coefficient, the potential action mechanism of the circular RNA associated with the drug sensitivity can be explained, and the guidance of medical research is facilitated.
Owner:UNIV OF ELECTRONICS SCI & TECH OF CHINA

Probiotic and prebiotic composition for improving intestinal microecology and assisting in resisting food allergy and application of probiotic and prebiotic composition

The invention belongs to the technical field of biological medicines, and discloses a probiotic and prebiotic composition for improving intestinal microecology and assisting in resisting food allergy, and the composition comprises bifidobacterium longum and oligosaccharide in a mass ratio of (1-3): (1-3). The probiotic and oligosaccharide composition provided by the invention is clear in mechanism and wide in application range, and the effect of relieving food anaphylactic reaction is achieved by enhancing intestinal barriers and regulating intestinal flora. And under the participation of the oligosaccharide, the anti-allergic effect of the probiotics is obviously enhanced. The invention can solve the problem that the existing anti-allergic medicine treats both symptoms and root causes, simplifies the composition, defines the action mechanism of the composition, and expands the range of applicable people.
Owner:NANKAI UNIV

Application of bakuchiol in preparation of drug for resisting pseudomonas aeruginosa infection

The invention provides an application of bakuchiol in preparation of a drug for resisting pseudomonas aeruginosa infection. A research result verifies that bakuchiol obviously inhibits gene expression related to a PQS quorum sensing system of the pseudomonas aeruginosa under the condition that normal growth of the pseudomonas aeruginosa is not hindered. Further analysis shows that the action mechanism of the bakuchiol definitely points to a transcriptional activator PqsR of a PQS quorum sensing system, in addition, the bakuchiol remarkably reduces the athletic ability of pseudomonas aeruginosa in an experiment, remarkably reduces gene expression related to a virulence factor, and has a significant effect in infection models of plants and animals. The bakuchiol shows the effect of remarkably weakening the toxicity of the pseudomonas aeruginosa on the Chinese cabbage and the caenorhabditis elegans.
Owner:YANAN UNIV +1

Ploretin derivative and application of phloretin derivative in preparation of medicine for treating diabetes mellitus

The invention discloses a phloretin derivative and application thereof in preparation of a medicine for treating diabetes, relates to the technical field of medicines, and in particular relates to a compound as shown in a formula (1) and alpha-glucosidase inhibitory activity of the compound. Pharmacological experiment results show that the compound shown in the formula (1) has extremely high alpha-glucosidase inhibitory activity, so that the generation of glucose is inhibited, and the pharmacological action of resisting diabetes mellitus is exerted through the action mechanism.
Owner:CHINA AGRI UNIV

In-vitro skin blood vessel immune model as well as preparation method and application thereof

The invention provides an in-vitro skin blood vessel immune model as well as a preparation method and application thereof. THP-1 human monocyte leukemia cells are induced to be differentiated into M0 type macrophages, and then the M0 type macrophages are respectively induced into M1 type macrophages and / or M2 type macrophages; then co-culturing the M1 type and / or M2 type macrophages and vascular endothelial cells to form a vascular immune model; finally, the 3D skin model is placed on the blood vessel immune model, external stimulation is conducted, and the in-vitro skin blood vessel immune model is constructed. The in-vitro skin blood vessel immune model can be used for repairing skin barriers, inflammation pathways, blood vessel metabolism, the expression level of genes or proteins related to extracellular matrixes, vascular endothelial cells, the proliferation and migration ability of activated macrophages and the like. The seven feature dimensions of the physiological structure feature of the skin model are used for screening the to-be-tested sample and exploring the action mechanism, and the method has the characteristics of rapidness, multiple screening dimensions, high accuracy, low construction difficulty, low cost and high universality.
Owner:YUNNAN YUNKE CHARACTERISTIC PLANT EXTRACTION LABORATORY CO LTD +1

Bionic nano-drug for resisting subcutaneous drug-resistant bacterial infection as well as preparation method and application of bionic nano-drug

The invention belongs to the technical field of medicines, and particularly relates to a bionic nano-drug for resisting subcutaneous drug-resistant bacterial infection as well as a preparation method and application thereof. Dopamine hydrochloride is added in the synthesis process of a metal-organic framework to prepare a dandelion-shaped carbon nano-enzyme precursor, then the nano-enzyme precursor is carbonized to obtain a carbon nano-enzyme with targeting property, photoresponse and peroxidase activity, and finally berberine hydrochloride is loaded on the carbon nano-enzyme to obtain the bionic nano-drug. The bionic nano-drug provided by the invention firstly has good biocompatibility, secondly has a unique dandelion-shaped form, is beneficial to playing a targeting role, and finally has relatively strong light response capability in a near-infrared region, and can synergistically and efficiently sterilize through action mechanisms of antibacterial drugs, photothermal therapy and chemical kinetics, so that the bionic nano-drug has a good application prospect. The compound has an important application value in preparation of drugs for treating subcutaneous drug-resistant bacterium infection.
Owner:JILIN AGRICULTURAL UNIV

Pharmaceutical composition for preventing / treating Alzheimer's disease

The invention belongs to the technical field of biological medicines, and particularly relates to a pharmaceutical composition for preventing / treating Alzheimer's disease. According to the pharmaceutical composition based on the NPAFP protein provided by the invention, the synergistic effect of natural and artificially synthesized compounds is utilized, so that the pharmaceutical composition can play a role in a plurality of pathological levels, and the AD symptom is remarkably improved. The composition has the remarkable effects of resisting oxidation, resisting inflammation, promoting A beta removal, improving mitochondrial quality, reducing A beta 42 secretion and pathological states caused by Tau PFF and the like, and can protect neurons by adjusting the metabolic process. By screening and optimizing the compound with synergistic effect, the action mechanism of the compound is further defined, a novel safe and efficient potential solution is provided for AD treatment, and the compound has wide clinical application prospect. The medicine is high in safety, strong in specificity, simple and convenient in preparation method and suitable for mass production.
Owner:HIGENE (HANGZHOU) BIOTECHNOLOGY CO LTD

Stem cell preparation for improving function degeneration of prostatitis as well as preparation method and application of stem cell preparation

The invention discloses a stem cell preparation for improving function degeneration of prostatitis and a preparation method and application thereof, and relates to the technical field of stem cells, the stem cell preparation is prepared from mesenchymal stem cells UC-MSCs and ADSCs according to the cell concentration ratio of 1: 2, hyaluronic acid hydrogel is used as a delivery carrier, and the stem cell preparation is prepared from the mesenchymal stem cells UC-MSCs and ADSCs according to the cell concentration ratio of 1: 2. And two key auxiliary components of juniperus formosana extract and mulberry extract are introduced. Wherein the optimal combination of the UC-MSCs and the ADSCs significantly enhances the anti-inflammatory ability and the tissue regeneration effect; the hyaluronic acid hydrogel carrier system effectively improves the targeting delivery efficiency of the stem cells and prolongs the action time; the two natural active components of the juniperus formosana extract and the mulberry extract synergistically improve the local microenvironment of prostate and inhibit inflammatory response and fibrosis process. The stem cell preparation developed through a multi-component synergistic effect mechanism has the characteristics of high targeting property, lasting treatment effect, high safety and the like, and a new strategy is provided for clinical treatment of prostatitis.
Owner:SHENZHEN TAIYI SAIL BIOTECHNOLOGY CO LTD

Biological material for repairing ovarian function as well as preparation method and application of biological material

The invention provides a biological material for repairing an ovarian function as well as a preparation method and application thereof, and relates to the technical field of biological materials, a large number of experiments prove that specific biological protein components for reversing the ovarian function in extracellular vesicles are growth differentiation factor 9 (GDF-9) for repairing an ovary, and the biological material has the advantages that the ovarian repairing function mechanism of the specific biological protein components for reversing the ovarian function in the extracellular vesicles is found; according to the present invention, the GDF-9 extracellular vesicles (GDF-9Over-existed Extracellular vesicles, GOEs) are adopted as the active substance, such that the component is effectively extracted and purified so as to achieve the target of targeted therapy.
Owner:BEIJING HOSPITAL +1

Umami peptide from penaeus monodon and application thereof

The invention discloses umami peptide derived from penaeus monodon and application of the umami peptide, and belongs to the technical field of bioactive peptide. The umami peptides have 11 types, and the amino acid sequences of the umami peptides are respectively ACWVPCEK, QRMMQ, DAKKACW, DRM, RMM, PDPDPT and the like, and are shown as SEQ ID NO.1-11. The umami peptide can be used as or used for preparing a flavor enhancer. According to the invention, the umami peptide is obtained from myosin of penaeus monodon by using a rapid screening technology, the umami strength of QRMMQ is the strongest, the umami threshold value of PDPDPT is the lowest, and ACWVPCEK has a synergistic fresh-increasing effect. According to the method, a marine-derived umami peptide library is enriched, the economic value of the penaeus monodon is improved, meanwhile, key amino acids for combining the umami peptide with an umami receptor and an action mechanism are further researched, and reference is provided for researching the freshness presenting mechanism of the umami peptide.
Owner:SANYA INST OF OCEANOGRAPHY OCEAN UNIV OF CHINA

Prediction method for quantitative activity of endocrine disrupter

The invention discloses an endocrine disrupter quantitative activity prediction method, and relates to the field of endocrine disrupter virtual screening, and the method comprises the following steps: obtaining nuclear receptor in vitro experiment data, removing repeated data in the experiment data, and removing a compound set which does not contain simplified molecular linear input specification SMILES expression; a molecular fingerprint method is adopted to extract first-level, second-level and third-level feature structures of the compound. For each compound cluster, constructing a quantitative prediction model based on machine learning or quantitative read-stress for predicting the quantitative activity value of the compound; aiming at the low quantitative activity prediction efficiency of the endocrine disrupter in the prior art, multilevel structure characteristics of compounds are extracted, and corresponding quantitative prediction models are constructed for compound structure clusters of different scales. Through molecular docking and molecular dynamics simulation, the interaction mechanism and the like of the endocrine disrupter and the nuclear receptor are researched from the perspective of structural biology, and the efficiency is improved.
Owner:NANJING UNIV

Method and system for utilizing artificial intelligence to identify compounds for use in combination therapy

A system and method are herein disclosed. The system and method use a generative AI agent to analyze and identify synergistic blends of natural compounds for combination therapies by leveraging an array of specialized modes to access data from a multitude of sources including patient medical history (including test results, drug history, and imaging) to improve the efficacy of compounds, including traditional medicine, in line with combination therapy principles, aimed at: enhanced efficacy, decreased toxicity, improved dosage, and reduced drug resistance. In this way, the generative AI agent determines cross-therapeutic similarities and / or dissimilarities between pharmaceutical, naturopathic, homeopathic, and nutraceutical compounds along a plurality of compound property vectors such as efficiency, efficacy, toxicity, effects, side-effects, chemistry, pharmacology, pharmacokinetics, mechanisms of action, and pharmacodynamics, thereby enabling the proposition of cross-disciplinary and transdisciplinary therapeutic analyses and the identification of synergistic effects in combination therapies.
Owner:WITHROW MIKE

Application of VBIT-4 or pharmaceutically acceptable salt thereof in preparation of medicine for preventing or treating vitiligo and complications thereof

The invention relates to application of VBIT-4 or pharmaceutically acceptable salt thereof in preparation of drugs for preventing or treating vitiligo and complications thereof. A large number of modern pharmacological scientific researches and in-vivo pharmacodynamic tests prove that VBIT-4 has a treatment effect on a leucoderma mouse model and inhibits synthesis of inflammatory factors and chemotactic factors in a leucoderma mouse skin lesion area. The mechanism of the invention is that VBIT-4 inhibits the expression of inflammatory factors and chemotactic factors in skin tissues so as to treat leucoderma, compared with the existing treatment means, VBIT-4 can promote the compound color of pigments in a skin lesion region on the back of a leucoderma mouse, has no obvious toxicity, and reduces the expression level of inflammatory factors (IL-1beta, IL-6 and IFN-alpha) and chemotactic factors (CXCL9 and CXCL10). In conclusion, the VBIT-4 is clear in action mechanism, remarkable in effect and free of obvious side effects, and has remarkable advantages and progress compared with existing drugs.
Owner:CHANGZHOU UNIV

Antibody drug conjugate as well as preparation method and application thereof

The invention relates to an antibody drug conjugate which is shown in a formula (I) and contains two or more bioactive molecules with different action mechanisms, a preparation method of the antibody drug conjugate, and application of the antibody drug conjugate in prevention and / or treatment of diseases related to abnormal cell activity, including but not limited to prevention and / or treatment of tumor diseases. # imgabs0 #
Owner:MEDILINK THERAPEUTICS (SUZHOU) CO LTD

Construction method and application of gastric cancer treatment effect evaluation model of CAR-T cells

The invention discloses a construction method and application of a gastric cancer treatment effect evaluation model of CAR-T cells, and the constructed gastric cancer treatment effect evaluation model of the CAR-T cells comprises a CAR-T cell and gastric cancer organ co-culture killer dynamic detection system and a CAR-T cell, intestine organ and lung organ co-culture safety evaluation system. Based on a CAR-T cell and gastric cancer organoid co-culture lethality dynamic detection system, the process that CAR-T cells act on gastric cancer organoid can be dynamically observed through a living cell imaging method, then the action mechanism of the CAR-T cells for treating solid tumors is studied, and meanwhile, based on a CAR-T cell, intestine organoid and lung organoid co-culture safety evaluation system, the CAR-T cells and the gastric cancer organoid co-culture lethality dynamic detection system can be used for evaluating the CAR-T cells and the gastric cancer organoid co-culture lethality. Compared with the prior art, the preclinical model has the advantages that the effect of the CAR-T cells on gastric cancer para-tissues and other tissue-derived organs can be detected, and safety evaluation is carried out, so that the preclinical model for more comprehensively detecting the gastric cancer treatment effect of the CAR-T cells is obtained, and the research on CAR-T cell targets is facilitated.
Owner:NANCHANG UNIV

Schizophrenia risk structure variation identification and function evaluation method based on three-generation sequencing

The invention discloses a schizophrenia risk structure variation identification and function evaluation method based on three-generation sequencing, and relates to the field of molecular biology, whole genome sequencing is performed on peripheral blood DNA of a patient through three-generation sequencing, multi-tool joint detection is adopted, multi-sample results are integrated, and a high-confidence SV data set is generated; through cross-queue comparison, the patient specific SV is screened, and the high-risk potential pathogenic SV is identified in combination with an SV priority ordering tool SVJudge. By combining transcription factor binding analysis, SCZ drug target data and histocyte specific expression data, the influence of SV on gene regulation is evaluated, and the potential action mechanism of SV in SCZ is analyzed. The SCZ risk gene is screened based on SVJudge scoring and patient carrying conditions, the genetic risk and pathogenic mechanism of the SCZ are analyzed and verified through pathway enrichment, a protein interaction network and a functional module, and a new technical means and theoretical basis are provided for genetic research of the SCZ.
Owner:FUDAN UNIVERSITY

Application of Prevotella copri as children metabolism-related fatty liver disease biomarker and therapeutic target

The invention discloses application of Prevotella copri as a children's metabolism-related fatty liver disease (MASLD) biomarker and a therapeutic target, relates to the fields of medical microbiology and metabonomics, and explores biological characteristics of the Prevotella copri and an action mechanism of the Prevotella copri in children's metabolism-related fatty liver disease (MASLD). The invention also analyzes the effect of Prevotella copri and its metabolite 5-aminovaleric acid in the development of children's metabolism-related fatty liver disease (MASLD), and provides a basis for developing a method for treating metabolism-related fatty liver disease (MASLD) based on intestinal microorganisms. According to the present invention, the Prevotella copri is subjected to intragastric administration to the mouse fed with the high fat diet, such that the liver fat change and the intestinal flora disorder aggravating are found; the metabolite 5-amino valeric acid of the Prevotella copri can be used for aggravating the adiposis of the liver cells. Therefore, the Prevotella copri and the metabolite 5-aminovaleric acid of the Prevotella copri can be used as a biomarker and a therapeutic target for diagnosis, treatment, prognosis evaluation or drug screening of the MASLD (Metabolism-related Fatty Liver Disease) of children.
Owner:SHANGHAI INST OF PEDIATRIC RES

Traditional Chinese medicine composition, preparation method thereof and application of traditional Chinese medicine composition in preparation of medicine for preventing and treating stress insomnia

The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition, a preparation method thereof and application of the traditional Chinese medicine composition in preparation of medicines for preventing and treating stress insomnia. The composition provided by the invention is composed of vinegar-processed rhizoma cyperi, green tangerine peel, pinellia ternate, poria with hostwood, salvia miltiorrhiza, ginseng, rhizoma acori graminei, nacre mother of pearl, crude dragon bone and ginger, and the comprehensive advantages of the composition in treatment of stress insomnia are shown through a multi-target and multi-channel regulation mechanism in combination with significant regulation effects of GO function enrichment and KEGG signal channels. The multi-layer action mechanism provides a unique treatment potential for the formula, and particularly has an important clinical application prospect in the aspect of coping with complex stress response and nerve dysfunction.
Owner:THE SIXTH MEDICAL CENT OF THE CHINESE PEOPLES LIBERATION ARMY GENERAL HOSPITAL

Application of ganoderan GLP-2 in preparation of medicine for improving atopic dermatitis

The invention belongs to the technical field of new application of medicines, and particularly relates to application of ganoderan GLP-2 in preparation of a medicine for improving atopic dermatitis. The structural formula of the ganoderma lucidum polysaccharide GLP-2 is as follows: # imgabs0 #, wherein m is equal to 10; n = 7. The research on the action mechanism of the ganoderan on mice with atopic dermatitis is discussed, theoretical guidance and practical experience are provided for further research of the ganoderan and products thereof, and the method has important theoretical value and application value.
Owner:SHANDONG AGRICULTURAL UNIVERSITY

High-throughput drug screening platform for rapid and efficient identification of compounds that modulate mitochondrial function

An automated high throughput screening platform for identification of compounds and genomic constructs having mitochondrial function modulating activity and compounds so identified are provided. Use of such compounds for modulating mitochondrial function are also disclosed. A high-throughput screening method of determining genetic mechanisms of action for therapeutic or toxic agents in genetic or pharmacologic models of disease are also provided.
Owner:THE CHILDRENS HOSPITAL OF PHILADELPHIA

Application of aromatic sulfonamide compound in preparation of medicine for preventing and treating liver injury

The invention provides application of an aromatic sulfonamide compound in preparation of a medicine for preventing and treating liver injury. The aromatic sulfonamide compound BC2059 provided by the invention can be used for inhibiting transcription and protein synthesis of related genes of Fibronectin and CollagenI in hepatic stellate cells, and plays a role in treating liver injury mice induced by bile duct ligation and carbon tetrachloride. The invention provides a potential drug molecule with a new action mechanism for treating liver injury.
Owner:ZHEJIANG UNIV +1